Collaborative for Effective Prescription Opioid Policies (CEPOP) Company Profile

13:58 EDT 24th March 2018 | BioPortfolio

News Articles [2176 Associated News Articles listed on BioPortfolio]

Expert Panel to Discuss the National Opioid Emergency and Need for Medication Assisted Treatment

President Trump declared the opioid epidemic a national public health emergency, with more than 175 American lives lost daily to opioid overdose. Fewer than 3 percent of Americans...

Household prescription opioid exposure linked to small increased risk of opioid initiation

1. Household member opioid prescription was linked to a small increase in the risk of personal opioid prescription compared to a household non-steroidal anti-inflammatory (NSAID) prescription. 2. The ...

CMS Proposes Policies to Lower the Cost of Prescription Drugs and Combat the Opioid Crisis

Today, the Centers for Medicare & Medicaid Services (CMS) issued a proposed rule that includes a number of changes that, if finalized, will ensure that Part D Medicare enrollees have access to mor...

Does prescription opioid use by one household member increase risk of prescribed use in others?

Living in a household with a prescription opioid user may be associated with increased risk of prescription opioid use by other household members.

Length of opioid prescription spell highest risk for misuse after surgery

(Beth Israel Deaconess Medical Center) With opioid overdoses now a leading cause of nonintentional death in the United States, data show most of these deaths can be traced back to an initial prescript...

'Drug Courts,' Treatment Focus of New White House Opioid Strategy

WEDNESDAY, Nov. 1, 2017 -- Steering opioid addicts toward treatment programs instead of prisons, while tightening federal policies on opioid prescribing, could curb the opioid epidemic, President Dona...

Minnesota renews push for tax on prescription opioids

(Reuters) - Citing rising opioid fatalities, Minnesota Governor Mark Dayton on Wednesday announced a renewed legislative proposal to tax prescription opioid pills to help fund treatment.

Study finds medical cannabis is effective at reducing opioid addiction

Drugs and Medications [828 Associated Drugs and Medications listed on BioPortfolio]

Levorphanol tartrate [Roxane Laboratories, Inc]


Levo-dromoran™ c-ii (levorphanol tartrate) ampuls, vials, tablets potent synthetic opioid for parenteral or oral administration [Valeant Pharmaceuticals International]

LEVO-DROMORAN™ C-II (levorphanol tartrate) AMPULS, VIALS, TABLETS Potent Synthetic Opioid For Parenteral Or Oral Administration

Tramadol hydrochloride [Northstar RxLLC]

Rx Only

Opana [Endo Pharmaceuticals, Inc]

ENDO PHARMACEUTICALS 003466/September 2006 OPANA (Oxymorphone Hydrochloride) INJECTION 1mg/mL CII Opioid Analgesic Rx only

Butrans [Purdue Pharma L.P.]

These highlights do not include all the information needed to use Butrans safely and effectively. See full prescribing information for Butrans. Butrans (buprenorphine) Transdermal System for transderm...

PubMed Articles [1900 Associated PubMed Articles listed on BioPortfolio]

Association of Household Opioid Availability and Prescription Opioid Initiation Among Household Members.

Increases in prescription opioid use in the United States have been attributed to changing prescribing guidelines and attitudes toward pain relief; however, the spread of opioid use within households ...

Between a rock and a hard place: Prescription opioid restrictions in the time of fentanyl and other street drug adulterants.

Non-medical prescription opioid use (NMPOU) has increased alarmingly across Canada and resulted in strict prescribing restrictions on opioids. Despite a clear need to reduce opioid prescriptions in re...

Prevalence of and Comorbid Health Conditions Associated With Pediatric Prescription Opioid Use in the US.

Prescription opioids are among the most effective analgesics to treat moderate to severe pain; however, little is known about the use of prescription opioids in children, particularly those receiving ...

Gabapentin, opioids, and the risk of opioid-related death: A population-based nested case-control study.

Prescription opioid use is highly associated with risk of opioid-related death, with 1 of every 550 chronic opioid users dying within approximately 2.5 years of their first opioid prescription. Althou...

Association of childhood abuse and prescription opioid use in early adulthood.

Previous research has examined the association of childhood abuse with opioid misuse and dependence in adulthood. However, little research has focused specifically on prescription opioids, and no stud...

Clinical Trials [2488 Associated Clinical Trials listed on BioPortfolio]

Collaborative Care From the ED for Trauma Patients With Prescription Drug Misuse

Injured trauma patients in the Emergency Department (ED) may be a particularly important group to target for screening and intervention for prescription drug misuse (PDM). These patients h...

Improving Treatment Outcomes for Prescription Opioid Dependence

Overall, this proposal seeks to improve treatment strategies for the significant public health problem of prescription opioid dependence by determining whether gabapentin, a non-narcotic p...

A Qualitative Study to Assess the Content Validity of the Prescription Opioid Misuse and Abuse Questionnaire

The purpose of this study is to evaluate the patient usability and reliability of the POMAQ survey to evaluate opioid misuse and abuse among adults with chronic moderate to severe pain, in...

Program for Pain & Prescription Opioid Use in Pregnancy

Pregnant women using prescription opioid medication (pain medications) are invited to take part in a program for the reduction of pain and prescription opioid misuse.

A Quantitative Study to Assess the Construct Validity of the Prescription Opioid Misuse and Abuse Questionnaire

The purposes of this study are to evaluate the validity and reproducibility of the POMAQ to identify opioid abuse and misuse behaviors among participants who have chronic pain which requir...

Companies [1631 Associated Companies listed on BioPortfolio]

Collaborative for Effective Prescription Opioid Policies (CEPOP)

Pear Therapeutics

Pear Therapeutics is the leader in prescription digital therapeutics. The company’s approach is to integrate clinically-validated software applications with previously approv...

MonoSol Rx, LLC

MonoSol Rx is a specialty pharmaceutical company leveraging its proprietary PharmFilm® technology to deliver drugs in films. PharmFilm® is designed to benefit patients by improving the convenience, ...


Priska™ is designed to provide assessment data associated with a patient’s risk for opioid abuse, as well as other mental health conditions. The Opioid Risk Tool assessm...

Lightlake Therapeutics Inc

Lightlake Therapeutics is an early stage biopharmaceutical company aiming to build a solid platform of pharmacological treatments based on our expertise using opioid antagonists. ...

More Information about "Collaborative for Effective Prescription Opioid Policies (CEPOP)" on BioPortfolio

We have published hundreds of Collaborative for Effective Prescription Opioid Policies (CEPOP) news stories on BioPortfolio along with dozens of Collaborative for Effective Prescription Opioid Policies (CEPOP) Clinical Trials and PubMed Articles about Collaborative for Effective Prescription Opioid Policies (CEPOP) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Collaborative for Effective Prescription Opioid Policies (CEPOP) Companies in our database. You can also find out about relevant Collaborative for Effective Prescription Opioid Policies (CEPOP) Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record